ES551203A0 - Procedimiento para preparar 17 beta-acetoxi-8,13-expoxi-ialfa.6beta,9alfa-trihidroxilabol-14-en-11-ona,sus compuestos analogos y derivados. - Google Patents

Procedimiento para preparar 17 beta-acetoxi-8,13-expoxi-ialfa.6beta,9alfa-trihidroxilabol-14-en-11-ona,sus compuestos analogos y derivados.

Info

Publication number
ES551203A0
ES551203A0 ES551203A ES551203A ES551203A0 ES 551203 A0 ES551203 A0 ES 551203A0 ES 551203 A ES551203 A ES 551203A ES 551203 A ES551203 A ES 551203A ES 551203 A0 ES551203 A0 ES 551203A0
Authority
ES
Spain
Prior art keywords
dsm
compound
formula
strain
see diagramm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551203A
Other languages
English (en)
Other versions
ES8705873A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES551203A0 publication Critical patent/ES551203A0/es
Publication of ES8705873A1 publication Critical patent/ES8705873A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES551203A 1985-01-26 1986-01-24 Procedimiento para preparar 17 beta-acetoxi-8,13-expoxi-ialfa.6beta,9alfa-trihidroxilabol-14-en-11-ona,sus compuestos analogos y derivados. Expired ES8705873A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853502685 DE3502685A1 (de) 1985-01-26 1985-01-26 Forskolin, seine analoge und derivate, verfahren zu deren herstellung mittels mikrobieller umwandlungen und die anwendung dieser verbindungen als arzneimittel

Publications (2)

Publication Number Publication Date
ES551203A0 true ES551203A0 (es) 1987-05-16
ES8705873A1 ES8705873A1 (es) 1987-05-16

Family

ID=6260903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551203A Expired ES8705873A1 (es) 1985-01-26 1986-01-24 Procedimiento para preparar 17 beta-acetoxi-8,13-expoxi-ialfa.6beta,9alfa-trihidroxilabol-14-en-11-ona,sus compuestos analogos y derivados.

Country Status (8)

Country Link
EP (1) EP0189801B1 (es)
JP (1) JPS61180782A (es)
AT (1) ATE40362T1 (es)
DE (2) DE3502685A1 (es)
DK (1) DK37586A (es)
ES (1) ES8705873A1 (es)
GR (1) GR860206B (es)
PT (1) PT81900B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963537A (en) * 1985-03-01 1990-10-16 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
IN163242B (es) 1985-05-03 1988-08-27 Hoechst India
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
US4740522A (en) * 1986-08-28 1988-04-26 Hoechst-Roussel Pharmaceuticals Inc. Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
IN166900B (es) * 1987-06-03 1990-08-04 Hoechst India
AT389114B (de) * 1987-10-08 1989-10-25 Hoechst Ag 7-acyloxy-6-aminoacyloxypolyoxylabdane und verfahren zu ihrer herstellung
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
US5177207A (en) * 1989-01-11 1993-01-05 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US4999351A (en) * 1989-01-11 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US5145855A (en) * 1989-07-06 1992-09-08 Hoechst Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
US5093336A (en) * 1989-07-06 1992-03-03 Hoechat-Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
JP5933419B2 (ja) * 2012-11-26 2016-06-08 株式会社シャローム ジテルペン化合物、美白剤およびジテルペン化合物の製造方法
JP5933420B2 (ja) * 2012-11-26 2016-06-08 株式会社シャローム 新規化合物、美白剤および前記化合物の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
DE3314999A1 (de) * 1983-04-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verwendung des diterpen-derivates forskolin zur immunstimulation
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
WO1985002616A1 (en) * 1983-12-14 1985-06-20 Brown University Research Foundation Treatment of metastasis

Also Published As

Publication number Publication date
GR860206B (en) 1986-05-21
DK37586D0 (da) 1986-01-24
DE3502685A1 (de) 1986-09-04
PT81900B (pt) 1988-07-01
JPS61180782A (ja) 1986-08-13
DE3661915D1 (en) 1989-03-02
DK37586A (da) 1986-07-27
EP0189801A1 (de) 1986-08-06
ATE40362T1 (de) 1989-02-15
ES8705873A1 (es) 1987-05-16
EP0189801B1 (de) 1989-01-25
PT81900A (de) 1986-02-01

Similar Documents

Publication Publication Date Title
ES551203A0 (es) Procedimiento para preparar 17 beta-acetoxi-8,13-expoxi-ialfa.6beta,9alfa-trihidroxilabol-14-en-11-ona,sus compuestos analogos y derivados.
KR930006157A (ko) 발효에 의한 아미노산의 제조방법
DK1454990T3 (da) Fremgangsmåde til fremstilling af olier som indeholder en umættet fedtsyre
Huang et al. Braunicene. A novel cyclic C32 isoprenoid from Botryococcus braunii
US3903145A (en) 9-Substituted fluorene-2-acetic acid derivatives
Abraham et al. Hydroxy-(methylbutenynyl)-benzoic acid and derivatives from Curvularia fallax
Noma et al. Enantio-and diastereoselectivity in the biotransformation of carveols by Euglena gracilis Z
Omori et al. Microbial oxidation of α-methylstyrene and β-methylstyrene
NO920849L (no) Fremgangsmaate for fremstilling av l-lysin ved fermentasjon
ES334165A1 (es) Procedimiento para la produccion del nuevo antibiotico sl 2266.
DK0414262T3 (da) Fremgangsmåde til fremstilling af antikonvulsive cycliske aminosyreforbindelser
YU60392A (sh) Novi glikopeptidi i postupak za njihovu proizvodnju
ES2084263T3 (es) Procedimiento para preparar un alfa-aminoacido y sus correspondientes esteres y amidas.
RU95104293A (ru) Способ получения ликопина
Otten et al. Microbial transformations of natural antitumor agents: oxidation of lapachol by Penicillium notatum
Davis et al. Formation of indole-3-carboxylic acid by Chromobacterium violaceum
Okamoto et al. Asymmetric microbial oxidation of formaldehyde dithioacetals
Ichiyama et al. Relationship between mycobacterial species and their carotenoid pigments
US3522146A (en) Increasing carotene yields in blakeslea trispora fermentation
JPS556A (en) Biochemical resolution
PT81692B (pt) Processo microbiologico para a preparacao de derivados de antraciclina e de composicoes farmaceuticas que os contem
US3697379A (en) Asymmetric reduction of seco-steroids
US3616226A (en) Process for producing unsaturated steroids
JPS55118428A (en) Biochemical resolution
Stratton et al. A new metabolite of Streptomyces venezuelae: D-Threo-1-p-aminophenyl-2-dichloroacetamido-1, 3-propanediol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401